James Bilsborrow, a Weitz & Luxenberg partner and practice group co-chair, is speaking at a virtual event titled “PFAS Litigation and Regulatory Developments Conference.” It…
Read MoreFirm News: Feb. 2017
Category: Drugs & Devices
W&L Investigates Rising Costs of Insulin
Weitz & Luxenberg is investigating the pricing of insulin by three major drug companies — Eli Lilly, Novo Nordisk, and Sanofi — following a…
Category: Our Firm
W&L Secures Pro Bono Decision Limiting Solitary Confinement for Death Row Inmates Who Have Been Granted New Sentences
Weitz & Luxenberg has secured a decision in the U.S. Court of Appeals for the Third Circuit that recognizes a constitutionally protected liberty interest…
Category: Drugs & Devices
Zimmer Biomet Recalls Comprehensive Reverse Shoulder, Cites High Fracture Rate, says FDA
Weitz & Luxenberg is currently accepting cases from people harmed by a faulty shoulder replacement device made by Zimmer Biomet.The medical device manufacturer issued…
Category: Drugs & Devices
Nurse Assist IV Syringes Linked to Dangerous Infections
Weitz & Luxenberg is currently accepting cases from people who became seriously ill or who had relatives die after they developed bloodstream infections due…
Category: Mesothelioma
Large Financial Settlement for Maintenance Worker Who Died from Mesothelioma
Employers in Pennsylvania who do not protect their workers from hazards faced on the job can be held liable. When that lack of corporate…